Interleukin 2 Ameliorates Autoimmune Neuroinflammation by Modulating the Balance of T Helper 17 Cells and Regulatory T Cells in Mouse
CONCLUSION: Low-dose IL-2 is a potential therapeutic strategy for EAE and MS.PMID:34452891
Source: Annals of Clinical and Laboratory Science - Category: Laboratory Medicine Authors: Jiannan Li Zhan Zhang Shuang Du Qi Guo Source Type: research
More News: Brain | Laboratory Medicine | Multiple Sclerosis | Neurology | Neuroscience | Science | Study